Chongqing, China

Lirong Xu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chongqing Zen Pharmaceutical Co., Ltd.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lirong Xu. Retrieved from https://idiyas.com/inventor/lirong-xu-ukpc9v14

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lirong Xu - Innovator in Pharmaceutical Chemistry

Introduction

Lirong Xu is a notable inventor based in Chongqing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical use. His work focuses on innovative solutions that address critical health issues.

Latest Patents

Lirong Xu holds a patent for "Ecdysterone synthesis derivative, preparation method and use thereof." This invention discloses a novel compound with the structure of formula I, or pharmaceutically acceptable salts or solvates thereof. The patent further details a method for preparing the compound, a pharmaceutical composition containing the compound, and its use in the preparation of a hypoglycemic medicament. He has 1 patent to his name.

Career Highlights

Lirong Xu is currently associated with Chongqing Zen Pharmaceutical Co., Ltd. His role in the company allows him to apply his innovative ideas in a practical setting, contributing to the advancement of pharmaceutical products.

Collaborations

Lirong Xu collaborates with talented individuals in his field, including Yongpeng Xia and Xiaolin Wang. Their combined expertise fosters a productive environment for research and development.

Conclusion

Lirong Xu's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. His work continues to pave the way for new treatments and advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…